Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DFTX compared with NAGE: revenue, margins and what each company keeps, and the suppliers and customers both name
DFTX
Definium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
NAGE
Niagen Bioscience, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
DFTX
Definium Therapeutics, Inc.
vs
NAGE
Niagen Bioscience, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
DFTX
Definium Therapeutics, Inc.
Change
30.34
▼
−7.21%
· post 30.39
· delayed
Mkt cap
$4.4B
Revenue
—
Revenue
—
NAGE
Niagen Bioscience, Inc.
Change
2.11
▼
−16.27%
· post 2.11
· delayed
After hours
Nov 5 '26
delayed
Mkt cap
$199.4M
Revenue
$27M
Q3 FY26
Revenue
$129M
FY25
vs
Compare
After hours
Nov 5 '26
delayed
DFTX
Definium Therapeutics, Inc.
vs
NAGE
Niagen Bioscience, Inc.
30.34
▼
−7.21%
post 30.39
delayed
Price
2.11
▼
−16.27%
post 2.11
delayed
$4.4B
Mkt cap
$199.4M
—
Revenue
$27M
Q3 FY26
—
Revenue
$129M
FY25
Change
Change
DFTX
30.34
▼
−7.21%
vs
NAGE
2.11
▼
−16.27%
After hours
Nov 5 '26
delayed
Co-movers
daily closes
Method
›
Moved together
DFTX
with
NAGE
Uncorrelated: r 0.10 · 499D.
No shared co-movers.
DFTX, solid
NAGE, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes